Table 1.
Baseline demographics and clinical features.
| Age at baseline, mean ± SD | 61.49 ± 11.36 |
| Sex, n (%) | |
| Male | 51 (63.75) |
| Female | 29 (36.25) |
| Race/ethnicity, n (%) | |
| White | 44 (55) |
| Black | 25 (31.25) |
| Asian | 2 (2.5) |
| Hispanic | 2 (2.5) |
| Other | 7 (8.75) |
| BMI, mean ± SD (kg/m2) | 34.42 ± 6.61 |
| Duration of diabetes Mean ± SD (years) |
16.91 ± 9.58 |
| Years on insulin Mean ± SD (years) |
7.59 ± 6.15 |
| Random C-peptide, mean ± SD (ng/ml) | 2.00 ± 1.06 |
| Use of noninsulin agents, n (%) | |
| Metformin | 54 (67.5) |
| Other | 44 (54.32) |
| Choice of GLP-1, n (%) | |
| Dulaglutide | 18 (22.5) |
| Liraglutide | 51 (63.75) |
| Semaglutide | 11 (13.75) |
| HbA1C, mean ± SD, % | 8.23 ± 1.45 |
| Total daily dose insulin, units | 82.39 ± 72.34 |